Seo Hee Ko

Seo Hee Ko

Auto-generated profile, based on publicly available information

Seo Hee Ko

Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
JKJae Chul Koh
Jae Chul Koh
YSYoung Song
Young Song
SKSo Yeon Kim
So Yeon Kim
SPSooyeun Park
Sooyeun Park
SKSeo Hee Ko
Seo Hee Ko
DHDong Woo Han
Dong Woo Han
In this retrospective study, data of 2,435 patients who received fentanyl and ropivacaine-based patient-controlled epidural analgesia (PCEA) for pain relief after elective surgery under general or spinal anesthesia were reviewed. Differences in postoperative pain, incidence of patient-controlled analgesia (PCA)-related adverse effects, and risk factors for the need for rescue analgesics for 48 hours postsurgery in young (age 20–39 years) and elderly (age ≥70 years) patients were evaluated. Although there were no significant differences in postoperative pain intensity between the two groups until 6 hours postsurgery, younger patients experienced greater postoperative pain intensity compared with older patients 6–48 hours postsurgery. While younger patients exhibited greater incidence of numbness, motor weakness, and discontinuation of PCA postsurgery, elderly patients exhibited greater incidence of hypotension, nausea/vomiting, rescue analgesia, and antiemetic administration. Upon multivariate analysis, low fentanyl dosage and history of smoking were found to be associated with an increased need for rescue analgesia among younger patients, while physical status classification III/IV and thoracic surgery were associated with a decreased need for rescue analgesia among the elderly. Discontinuation of PCA was more frequent among younger patients than the elderly (18.5% vs 13.5%, P=0.001). Reasons for discontinuation of PCA among young and elderly patients, respectively, were nausea and vomiting (6.8% vs 26.6%), numbness or motor weakness (67.8% vs 11.5%), urinary retention (7.4% vs 8.7%), dizziness (2.2% vs 5.2%), and hypotension (3.1% vs 20.3%). In conclusion, PCEA was more frequently associated with numbness, motor weakness, and discontinuation of PCA in younger patients and with hypotension, nausea/vomiting, and a greater need for rescue analgesics/antiemetics among elderly patients. Therefore, in order to minimize the adverse effects of PCEA and enhance pain relief, different PCEA regimens and administration/prevention strategies should be considered for young and elderly patients.

17 January 2018 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
DYDuck Mi Yoon
Duck Mi Yoon
KYKyung Bong Yoon
Kyung Bong Yoon
IBIn Chan Baek
In Chan Baek
SKSeo Hee Ko
Seo Hee Ko
SKShin Hyung Kim
Shin Hyung Kim

8 March 2024 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
SKSeo Hee Ko
Seo Hee Ko
JJJi Hae Jun
Ji Hae Jun
JOJu Eun Oh
Ju Eun Oh
ESEunah Shin
Eunah Shin
YKYoung-Lan Kwak
Young-Lan Kwak
JSJae-Kwang Shim
Jae-Kwang Shim
Acute kidney injury frequently occurs after cardiac surgery, and is primarily attributed to renal ischemia-reperfusion (I/R) injury and inflammation from surgery and cardiopulmonary bypass. Vitamin C, an antioxidant that is often depleted in critically ill patients, could potentially mitigate I/R-induced oxidative stress at high doses. We investigated the effectiveness of high-dose vitamin C in preventing I/R-induced renal injury. The ideal time and optimal dosage for administration were determined in a two-phase experiment on Sprague-Dawley rats. The rats were assigned to four groups: sham, IRC (I/R + saline), and pre- and post-vitC (vitamin C before and after I/R, respectively), with vitamin C administered at 200 mg/kg. Additional groups were examined for dose modification based on the optimal timing determined: V100, V200, and V300 (100, 200, and 300 mg/kg, respectively). Renal I/R was achieved through 45 min of ischemia followed by 24 h of reperfusion. Vitamin C administration during reperfusion significantly reduced renal dysfunction and tubular damage, more than pre-ischemic administration. Doses of 100 and 200 mg/kg during reperfusion reduced oxidative stress markers, including myeloperoxidase and inflammatory responses by decreasing high mobility group box 1 release and nucleotide-binding and oligomerization domain-like receptor 3 inflammasome. Overall beneficial effect was most prominent with 200 mg/kg. The 300 mg/kg dose, however, showed no additional benefits over the IRC group regarding serum blood urea nitrogen and creatinine levels and histological evaluation. During reperfusion, high-dose vitamin C administration (200 mg/kg) significantly decreased renal I/R injury by effectively attenuating the major triggers of oxidative stress and inflammation.

23 April 2024 in Asian Journal of Surgery
Verified
Journal Article
Open access
SHSung Yeon Ham
Sung Yeon Ham
JSJae-Kwang Shim
Jae-Kwang Shim
SLSak Lee
Sak Lee
SKSeo Hee Ko
Seo Hee Ko
SSSarah Soh
Sarah Soh
YKYoung-Lan Kwak
Young-Lan Kwak
Patients undergoing cardiac surgery for infective endocarditis (IE) are at a high risk of postoperative acute kidney injury (AKI) owing to heightened systemic inflammation. Therefore, we aimed to investigate the effect of dexmedetomidine on postoperative AKI in patients who underwent cardiac surgery for IE. A total of 63 patients who underwent cardiac surgery for IE were randomly assigned to receive either intravenous dexmedetomidine infusion of 0.4 μg kg-1 h-1 (DEX group) or normal saline infusion (control group) for 24 h after induction of anesthesia. The occurrence of AKI within seven days postoperation, epinephrine, norepinephrine, and interleukin-6 levels, as well as postoperative morbidities, were assessed. An intertrim analysis was conducted using Pocock's alpha spending function at α = 0.05 and β = 0.2. This trial was early terminated according to the results of interim analysis performed when 60 % of the pre-set number of patients have been collected. The incidence of AKI was significantly lower in the DEX group than in the control group (32.3 % vs. 9.4 %, p = 0.025). Patients in the DEX group had significantly lower epinephrine levels than those in the control group, whereas norepinephrine and interleukin-6 levels were similar. Perioperative mean arterial pressure or heart rate did not differ between the groups. Dexmedetomidine administration for 24 h starting from induction of anesthesia significantly reduced the incidence of postoperative AKI after cardiac surgery for IE (by 29 % vs. control) without hemodynamic side effects. This was accompanied by a significant attenuation of postoperative increase in serum epinephrine levels.

26 August 2025 in Anaesthesia
Verified
Journal Article
Open access
HCHee Won Choi
Hee Won Choi
HZHyun‐Soo Zhang
Hyun‐Soo Zhang
JSJae-Kwang Shim
Jae-Kwang Shim
JCJin Sun Cho
Jin Sun Cho
SKSeo Hee Ko
Seo Hee Ko
YKYoung-Lan Kwak
Young-Lan Kwak
Summary: Introduction: Peri‐operative anaemia is a common problem in patients undergoing cardiac surgery. Postoperative anaemia is not well understood relative to pre‐operative anaemia; limited data exist on haemoglobin recovery and mortality after discharge, especially in the era of restrictive transfusion practice. We aimed to investigate the associations of pre‐operative and persistent postoperative anaemia with 1‐year mortality in patients undergoing valvular heart surgery. Methods: We identified patients who had undergone valvular heart surgery and allocated them to one of four groups based on their pre‐operative (haemoglobin ≥ 130 g.l ‐1 and < 130 g.l ‐1 in men and ≥ 120 g.l ‐1 and < 120 g.l ‐1 in women) and postoperative (measured 2 months after surgery; haemoglobin ≥ 100 g.l ‐1 and < 100 g.l ‐1 in both men and women) anaemia status. The four groups were: pre‐ and postoperative non‐anaemia (non‐anaemia–non‐anaemia); pre‐operative anaemia–postoperative non‐anaemia (anaemia–non‐anaemia); pre‐ and postoperative anaemia (anaemia–anaemia); and pre‐operative non‐anaemia–postoperative anaemia (non‐anaemia–anaemia). The primary outcome was 1‐year mortality. Results: Data from 2486 patients were included. Pre‐operative anaemia was diagnosed in 1107 patients (44.5%) and 279 (11.9%) met the diagnostic criteria for persistent anaemia 2 months postoperatively. The overall 1‐year mortality rate was 3.3%. The highest rate was observed in the anaemia–anaemia group (17.8%), followed by the non‐anaemia–anaemia (13.1%), anaemia–non‐anaemia (2.9%) and non‐anaemia–non‐anaemia (0.5%) groups. Multivariable Cox regression analysis showed that the non‐anaemia–anaemia group had the highest risk of 1‐year mortality (adjusted hazard ratio 14.44, 95%CI 4.88–42.69), followed by the anaemia–anaemia group (adjusted hazard ratio 10.94, 95%CI 4.41–27.16). Discussion: Our study highlights the high prevalence of persistent anaemia following valvular heart surgery. Persistent anaemia 2 months postoperatively is associated with an increased risk of 1‐year mortality.

1 December 2017 in Medicine
Verified
Journal Article
Open access
PDF file
JKJae Chul Koh
Jae Chul Koh
JPJuyeon Park
Juyeon Park
NKNa Young Kim
Na Young Kim
AYAnn Hee You
Ann Hee You
SKSeo Hee Ko
Seo Hee Ko
DHDong Woo Han
Dong Woo Han
Propofol is a rapid, efficient hypnotic agent with antiemetic effects. However, a high dosage is related to hemodynamic abnormalities such as hypotension and bradycardia. Pretreatment with remifentanil can decrease injection pain and stabilize hemodynamics during the induction period. Remifentanil or midazolam in combination with propofol can provide synergistic or additive effects during anesthesia induction. However, the hypnotic doses of propofol required in patients who receive pretreatment with remifentanil or midazolam remain unclear. Patients aged 20 to 50 years who were scheduled to undergo surgery under general anesthesia were enrolled in this study. The patients were randomized into 3 groups using a computer-generated randomization table. Patients in Group P (Propofol) received only propofol for loss of consciousness, those in Group PR (Propofol-Remifentanil) received remifentanil prior to propofol, and those in Group PMR (Propofol-Midazolam-Remifentanil) received remifentanil and midazolam prior to propofol. After propofol administration, loss of both the eyelash reflex and verbal response represented success. The 95% effective dose of propofol for loss of consciousness in each group, which was the primary outcome, was determined using a modified biased coin up-and-down method. A total of 124 patients were initially enrolled. Of these, 4 were excluded, and the remaining 120 patients were randomized to each (n = 40) of the 3 groups. The 95% effective dose of propofol for loss of consciousness was 1.74 , 1.38, and 0.92 mg/kg in Groups P, PR, and PMR, respectively. Blood pressure decreased at 2 minutes after propofol administration in all the groups. However, compared with Group P, Groups PR and PMR exhibited a significant decrease in blood pressure. The effective dose of propofol for loss of consciousness could be decreased by 21% and 47% when remifentanil pretreatment was used without and with midazolam, respectively. However, the decrease in blood pressure was greater with pretreatment than sole propofol use. These findings suggest that the combination of remifentanil with or without midazolam may have no benefit on hemodynamic stability during induction using propofol. NCT02536690 (clinicaltrials.gov).